Free Trial

Inozyme Pharma (INZY) Insider Trading & Ownership

Inozyme Pharma logo
$3.01 +0.02 (+0.67%)
(As of 05:45 PM ET)

Inozyme Pharma (NASDAQ:INZY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.19%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$52,209.62
Get INZY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inozyme Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INZY Insider Buying and Selling by Quarter

Inozyme Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2024Douglas A TrecoCEOSell7,523$6.94$52,209.62  
(Data available from 1/1/2013 forward)

INZY Insider Trading Activity - Frequently Asked Questions

The list of insiders at Inozyme Pharma includes Axel Bolte, Douglas A Treco, Henric Bjorn Bjarke, Longitude Capital Partners Iii, Pivotal Bioventure Partners Fu, and Robert Lorne Hopfner. Learn more on insiders at INZY.

11.19% of Inozyme Pharma stock is owned by insiders. Learn more on INZY's insider holdings.

The following insiders have purchased INZY shares in the last 24 months: Pivotal Bioventure Partners Fu ($3,999,998.40), and Robert Lorne Hopfner ($3,174,031.88).

Insiders have purchased a total of 1,448,229 INZY shares in the last 24 months for a total of $7,174,030.28 bought.

The following insider sold INZY shares in the last 24 months: Douglas A Treco ($52,209.62).

Insiders have sold a total of 7,523 Inozyme Pharma shares in the last 24 months for a total of $52,209.62 sold.

Inozyme Pharma Key Executives

  • Dr. Douglas A. Treco Ph.D. (Age 66)
    CEO & Chairman
    Compensation: $591.88k
  • Mr. Axel Bolte M.B.A. (Age 52)
    M.Sc., Co-Founder, Senior Advisor & Director
    Compensation: $1.16M
  • Mr. Sanjay S. Subramanian M.B.A. (Age 47)
    M.S., Senior VP, CFO, Principal Accounting Officer & Corporate Secretary
    Compensation: $626.23k
  • Dr. Matthew Winton Ph.D. (Age 46)
    Senior VP & COO
    Compensation: $526.43k
  • Dr. Demetrios Braddock M.D.
    Ph.D., Co-Founder, Scientific Founder, Member of Scientific Advisory Board & Board Observer
  • Dr. Soojin Kim Ph.D.
    Senior VP & Chief Technical Operations Officer
  • Dr. David Thompson M.A.
    M.S., Ph.D., Senior VP, Chief Scientific Officer & Chief Development Officer
  • Mr. Stefan Riley
    Director of Investor Relations
  • Ms. Gayle Gironda
    Senior VP & Chief People Officer
  • Dr. Yves Sabbagh Ph.D.
    Chairman of Scientific Advisory Board & Senior VP


This page (NASDAQ:INZY) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners